#percy jackson#pjo#walker scobell#annabeth chase#pjo tv show
seen from United States
seen from Netherlands
seen from Australia
seen from United States
seen from Maldives
seen from United States
seen from United Kingdom
seen from United States
seen from South Korea
seen from United States
seen from United Kingdom
seen from Russia
seen from United States
seen from Maldives
seen from Morocco
seen from United States
seen from United States
seen from Türkiye
seen from United States
seen from Sri Lanka
Two clinical trials have concluded that the drugs anifrolumab and deucravacitinib are safe and effective in the treatment of systemic lupus
Lotta al lupus sistemico: aggiornamento dai congressi con afimetoran ed altre molecole rivoluzionarie
Lotta al lupus sistemico: aggiornamento dai congressi con afimetoran ed altre molecole rivoluzionarie
Il lupus è una malattia autoimmune che attacca gli organi e può essere fatale. Non esiste una cura, quindi i trattamenti attuali mirano a limitare i danni e migliorare i sintomi. Alcune di queste terapie devono essere iniettate, altre hanno gravi effetti collaterali e molte non sono molto efficaci. La malattia colpisce 5 milioni di persone in tutto il mondo, secondo la Lupus Foundation of…
View On WordPress
Clinical Trial Provides 'First Real Hope' of a Lupus Treatment in Half a Century
Clinical Trial Provides ‘First Real Hope’ of a Lupus Treatment in Half a Century
Lupus is a potentially fatal autoimmune disorder that impacts roughly 5 million people worldwide, and yet it still has no known cause or cure.
Today, most treatments come with a whole bunch of adverse side effects, and given how little we know, finding new avenues for medicine has proved extremely difficult.
In the past six decades, only one drug for lupushas been approved by the United…
View On WordPress
Top Pharma News of the Week - September 3rd
Top Pharma News of the Week – September 3rd
All The Most Important Pharmaceutical News Stories Of The Week – September 2018 – Week # 1 Novartis receives European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)
August 27, 2018
Novartis has announced that the European Commission (EC) has approved Kymriah® (tisagenlecleucel, formerly CTL019). The approved indications are for the treatment of pediatric and young…
View On WordPress
Read about clinical-trial results showing that the investigational therapy anifrolumab lowered lupus activity in combination with standard medications.